Help us determine whether surface electromyography is a valid tool for ALS diagnosis and tracking of disease progression
Active - Not Recruiting
Study Name
Intermuscular Coherence as a Biomarker for ALS (ALS-IMC)
PI
PI: Naoum Issa, MD, PhD (UChicago)
Site-PI: Nathan Carberry, MD
Site-PI: Nathan Carberry, MD
Study Type
Observational, Prospective, Biomarker
Eligible Population
- Patients with early diagnosed ALS and have one or more of the following signs and symptoms: muscle weakness, muscle twitching, loss of muscle mass, slurred speech, swallowing difficulty, shortness of breath, or abnormal reflexes.
- Healthy controls
Study Purpose/Goals
To determine whether surface electromyography is a valid tool for ALS diagnosis and tracking of disease progression
Procedures/Participation
- 1-hour study visit in Miami (# of visits may vary) including:
-
- Medical history review
- Collection of demographic information
- ALSFRS-R
- Surface EMG
Contact
Join our family - together, we can change the course of this disease.
Join our family
Together, we can change the course of this disease.
ALS Treatment
About Us
